Liposomal Nω-hydroxy-l-norarginine, a proof-of-concept: Arginase inhibitors can be incorporated in liposomes while retaining their therapeutic activity ex vivo

Author(s)

• Elena Markova
• Camilla Izabel Wolowczyk
• Aly Mohamed
• Alexandros Marios Sofias
• Montserrat Martin-Armas
• Rune Sundset
• Jens Berndtsson
• Sjoerd Hak
• Natasa Skalko Basnet

Affiliation

• UiT The Arctic University of Norway
• Norwegian University of Science and Technology
• Unknown
• University Hospital of North Norway
• University of Gothenburg
• SINTEF Industry / Biotechnology and Nanomedicine

DOI